Literature DB >> 25016791

[Causes and prevalence of visual impairment in Japan].

Rina Wako, Tsutomu Yasukawa, Aki Kato, Toyonori Omori, Susumu Ishida, Tatsuro Ishibashi, Yuichiro Ogura.   

Abstract

PURPOSE: To investigate the causes of visual impairment in Japan.
METHODS: The documents of 4,852 individuals with authorization of visual impairment registered between April 2007 and March 2010 in 7 randomly selected regions were reviewed.
RESULTS: The major causes of visual impairment were glaucoma (21.0%), diabetic retinopathy (15.6%), retinitis pigmentosa (12.0%), macular degeneration (9.5%) and chorioretinal atrophy (8.4%). Individuals over 70 years of age were predominant for glaucoma, those aged 50-69 years for diabetic retinopathy and those under 40 years of age for retinitis pigmentosa. Sixty-one percent of persons affected by glaucoma were severely handicapped. Macular degeneration increased with age especially in individuals over 80 years of age.
CONCLUSION: There was no difference in the order of major causes as compared with a previous report in 2001-2004. It is important to establish a central database system so that the data can be surveyed to provide more relevant information to understand current issues for handicapped persons and develop new prophylactic and therapeutic modalities.

Entities:  

Mesh:

Year:  2014        PMID: 25016791

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  9 in total

1.  Annual incidences of visual impairment during 10-year period in Mie prefecture, Japan.

Authors:  Kengo Ikesugi; Takako Ichio; Hideyuki Tsukitome; Mineo Kondo
Journal:  Jpn J Ophthalmol       Date:  2017-04-26       Impact factor: 2.447

2.  Vision-related quality of life in Japanese patients with wet age-related macular degeneration treated with intravitreal aflibercept in a real-world setting.

Authors:  Fumi Gomi; Hideyuki Migita; Toshiaki Sakaguchi; Hiromi Okada; Tamotsu Sugawara; Yusuke Hikichi
Journal:  Jpn J Ophthalmol       Date:  2019-10-31       Impact factor: 2.447

3.  Clinical practice pattern in management of diabetic macular edema in Japan: survey results of Japanese retinal specialists.

Authors:  Yuichiro Ogura; Fumio Shiraga; Hiroko Terasaki; Masahito Ohji; Susumu Ishida; Taiji Sakamoto; Akito Hirakata; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2016-10-08       Impact factor: 2.447

Review 4.  Management of diabetic macular edema in Japan: a review and expert opinion.

Authors:  Hiroko Terasaki; Yuichiro Ogura; Shigehiko Kitano; Taiji Sakamoto; Toshinori Murata; Akito Hirakata; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2017-12-05       Impact factor: 2.447

5.  Influence of comorbidities on the implementation of the fundus examination in patients with newly diagnosed type 2 diabetes.

Authors:  Taichi Kawamura; Izumi Sato; Hiroshi Tamura; Yoko M Nakao; Koji Kawakami
Journal:  Jpn J Ophthalmol       Date:  2017-12-05       Impact factor: 2.447

6.  Non-responsiveness to intravitreal aflibercept treatment in neovascular age-related macular degeneration: implications of serous pigment epithelial detachment.

Authors:  Norihiro Nagai; Misa Suzuki; Atsuro Uchida; Toshihide Kurihara; Mamoru Kamoshita; Sakiko Minami; Hajime Shinoda; Kazuo Tsubota; Yoko Ozawa
Journal:  Sci Rep       Date:  2016-07-11       Impact factor: 4.379

7.  Visual impairment and blindness in a population-based study of Mashhad, Iran.

Authors:  Hassan Hashemi; Mehdi Khabazkhoob; Mohammad Saatchi; Hadi Ostadimoghaddam; Abbasali Yekta
Journal:  J Curr Ophthalmol       Date:  2017-05-19

8.  The Clinical Effectiveness and Cost-Effectiveness of Screening for Age-Related Macular Degeneration in Japan: A Markov Modeling Study.

Authors:  Hiroshi Tamura; Rei Goto; Yoko Akune; Yoshimune Hiratsuka; Shusuke Hiragi; Masakazu Yamada
Journal:  PLoS One       Date:  2015-07-27       Impact factor: 3.240

9.  QD laser eyewear as a visual field aid in a visual field defect model.

Authors:  Chigusa Iyama; Yuta Shigeno; Eri Hirano; Mamoru Kamoshita; Norihiro Nagai; Misa Suzuki; Sakiko Minami; Toshihide Kurihara; Hideki Sonobe; Kazuhiro Watanabe; Hajime Shinoda; Kazuo Tsubota; Yoko Ozawa
Journal:  Sci Rep       Date:  2019-01-30       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.